Month 2 Culture Status and Treatment Duration as Predictors of Tuberculosis Relapse Risk in a Meta-Regression Model-Reference-Cited by-同舟云学术

Month 2 Culture Status and Treatment Duration as Predictors of Tuberculosis Relapse Risk in a Meta-Regression Model

Published:2013-08-05 Issue:8 Volume:8 Page:e71116
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wallis Robert S.,Wang Cunshan,Meyer Daniel,Thomas Neal

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Sustainable tuberculosis drug development;RS Wallis;Clin Infect Dis,2013

2. Biomarkers for tuberculosis disease activity, cure, and relapse;RS Wallis;Lancet Infect Dis,2010

3. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement;D Moher;PLoS Med,2009

4. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications;W Fox;Int J Tuberc Lung Dis,1999

5. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report;Am Rev Respir Dis,1978

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline and end-of-treatment host serum biomarkers predict relapse in adults with pulmonary tuberculosis;Journal of Infection;2024-07

2. Longitudinal analysis of host protein serum signatures of treatment and recovery in pulmonary tuberculosis;PLOS ONE;2024-02-29

3. Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease;Nature Reviews Drug Discovery;2024-02-28

4. Tuberculosis Severity Predictive Model Using Mtb Variants and Serum Biomarkers in a Colombian Cohort of APTB Patients;Biomedicines;2023-11-22

5. Serum biomarkers for monitoring response to tuberculosis treatment: an assessment of the effect of different covariates among slow and fast treatment responders;Biomarkers;2023-05-21